Citation: Ej. Favaloro et al., Possibility of potential VWD misdiagnosis or misclassification using LIA technology and due to presence of rheumatoid factor, AM J HEMAT, 66(1), 2001, pp. 53-56
Authors:
Torgeman, A
Mor-Vaknin, N
Zelin, E
Ben-Aroya, Z
Lochelt, M
Flugel, RM
Aboud, M
Citation: A. Torgeman et al., Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C, VIROLOGY, 281(1), 2001, pp. 10-20
Authors:
Torgeman, A
Ben-Aroya, Z
Grunspan, A
Zelin, E
Butovsky, E
Hallak, M
Lochelt, M
Flugel, RM
Livneh, E
Wolfson, M
Kedar, I
Aboud, M
Citation: A. Torgeman et al., Activation of HTLV-I long terminal repeat by stress-inducing agents and protection of HTLV-I-Infected T-cells from apoptosis by the viral Tax protein, EXP CELL RE, 271(1), 2001, pp. 169-179
Citation: J. Moore et al., Adult transient lupus anticoagulant patients maintain an acquired activated protein C resistance profile, THROMB HAEM, 84(4), 2000, pp. 735-736
Authors:
Wagner, A
Doerks, A
Aboud, M
Alonso, A
Tokino, T
Flugel, RM
Lochelt, M
Citation: A. Wagner et al., Induction of cellular genes is mediated by the Bel1 transactivator in foamy virus-infected human cells, J VIROLOGY, 74(10), 2000, pp. 4441-4447
Citation: A. Torgeman et al., Sp1 is involved in a protein kinase C-independent activation of human T cell leukemia virus type I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate, VIROLOGY, 254(2), 1999, pp. 279-287